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Initiation of DNA replication from within the Epstein–Barr virus (EBV) latent cycle origin oriP occurs once per cell cycle and is almost
entirely dependent upon cellular proteins. The human origin recognition complex (ORC) is recruited to oriP and orchestrates the events that
lead to the initiation of replication. EBNA-1, the sole viral protein required for oriP-plasmid replication, binds four sites within the replicator
but the role(s) it plays in the replication of oriP plasmids has not been elucidated. We investigated the recruitment of ORC to oriP in vivo and
show that the binding of EBNA-1 to the replicator is necessary for the association of the ORC subunit Orc2 with the replicator. The minimal
replicator of oriP consists of two EBNA-1 binding sites flanked by perfect 14-bp inverted repeats (a and b), but these repeats are dispensable
for the association of Orc2 with the replicator. A mutational analysis of the 14-bp repeats provided additional support for a role for the
telomere repeat binding protein 2 in oriP replicator function. We show that nucleotide differences between the oriP replicator of the B95-
8 and Raji EBV genomes are not solely responsible for the inefficient utilization of this origin in the Raji EBV genome.
D 2004 Elsevier Inc. All rights reserved.Keywords: Epstein–Barr virus; EBNA-1; oriP; ORC; Telomere repeat binding protein 2
Introduction Schildkraut, 1989; Little and Schildkraut, 1995). This latterEpstein–Barr virus (EBV) persistently infects greater
than 90% of the world’s adult population. These infections
are mostly benign, but for individuals living in certain
regions of the world and persons with immune deficiencies,
EBV infections are associated with an increased risk for the
development of specific cancers (Rickinson and Kieff,
1996). The viral genome usually exists in latently infected,
EBV-positive tumor cells as a single- or multiple-copy
plasmid that is replicated once per cell division cycle in
S phase (Yates, 1996). Replication initiation sites have been
mapped to a zone near the right end of the linear viral
genome (Norio and Schildkraut, 2001) and to a site
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of Medicine, New York, NY 10461.initiation site, together with the plasmid maintenance ele-
ment, is called oriP (Yates et al., 1984). The replicator of
oriP contains four binding sites for the EBV nuclear
antigen-1 (EBNA-1), the sole viral protein required for
the replication and maintenance of plasmids bearing oriP
(Lupton and Levine, 1985; Rawlins et al., 1985; Yates et
al., 1985). Although all four sites are required for replica-
tion to initiate efficiently within oriP, that is, once in every
cell cycle (Koons et al., 2001; Yates et al., 2000), minimal
replicator activity was observed when only EBNA-1 sites 4
and 3 flanked by 14-bp inverted repeats (a and b; Fig. 1)
are present (Koons et al., 2001). An approximately 120-bp
region of oriP containing the minimal replicator has been
termed DS in reference to a region of dyad symmetry
(Reisman et al., 1985). The origin has not yet been mapped
with nucleotide resolution but is localized within, or close
to, DS (Gahn and Schildkraut, 1989). The melting of oriP
DNA by EBNA-1 has not been detected (Frappier and
O’Donnell, 1992; Hearing et al., 1992) and EBNA-1 does
not possess the ATPase and DNA unwinding activities
associated with DNA helicases (Frappier and O’Donnell,
Fig. 1. The minimal replicator of oriP and flanking sequences. (A) The location of the plasmid maintenance element (FR) and the dyad symmetry element (DS)
within oriP are shown. The origin of DNA replication is located within the region indicated by the dashed line. (B) The nucleotide sequence of the EBV (B95-
8 strain) minimal replicator (EBNA-1 binding sites 4 and 3 and the flanking 14-bp inverted repeats a and b) and surrounding nucleotides (nt 8992–9137) are
shown. The EBNA-1 binding sites are indicated by rectangles and are numbered according to convention (Rawlins et al., 1985). The 14-bp repeats (a, b, and c)
that contain a conserved nonamer core sequence (5V-TAACCCTAA-3V; boldface type) are designated by arrows beneath the sequence. The asterisks over bp
positions 9008, 9019, and 9062 indicate nucleotides that differ between the B95-8 EBV genome and the Raji EBV genome (Koons et al., 2001; Salamon et al.,
2000).
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proteins likely carry out these essential steps in origin
activation.
Recently, the human origin recognition complex (ORC)
(Chaudhuri et al., 2001; Schepers et al., 2001) and the six-
subunit MCM complex (Chaudhuri et al., 2001; Ritzi et al.,
2003) were shown to associate with oriP in vivo. Originally
identified in Saccharomyces cerevisiae, ORC is a highly
conserved six-polypeptide complex that is essential for
eukaryotic DNA replication and plays a central role in the
assembly of the replication machinery (Bell, 2002). In
metazoans, pre-replication complexes containing all six
ORC polypeptides and MCM form at the M/G1 transition
of the cell cycle through the action of Cdc6 and Cdt1
(Depamphilis, 2003). Following the initiation of DNA
replication by Mcm10, MCM likely functions as the repli-
cative DNA helicase (Chong et al., 2000; Depamphilis,
2003; Ishimi, 1997; Labib et al., 2000). The recruitment
of ORC and MCM to oriP supported previous findings
implicating these cellular replication proteins in the initia-
tion of DNA replication within oriP (Adams, 1987; Shir-
akata et al., 1999; Yates and Guan, 1991), and the
determination that the Orc2 subunit is required for the
replication of an oriP-bearing plasmid in a human colon
carcinoma cell line provided direct evidence for a functional
role for ORC in oriP-plasmid replication (Dhar et al.,
2001b). Deletion of the DS element eliminated the associ-
ation of ORC and MCM with oriP (Chaudhuri et al., 2001;
Schepers et al., 2001), but the specific nucleotide or protein
requirements for the binding of these proteins to this
approximately 120-bp region of the EBV genome are notknown. EBNA-1 and ORC form a complex when chromatin
proteins are released from DNA by salt treatment (Schepers
et al., 2001), suggesting that these proteins contact one
another when bound to oriP DS. Embedded within the 14-
bp repeats of the minimal replicator is a nonamer repeat that
binds the telomere repeat binding factors 1 and 2 (TRF1 and
TRF2) as well as the telomere-associated protein hRAP1
(Deng et al., 2002, 2003). All three telomere-associated
proteins are bound to DS in vivo, but the way in which they
contribute to replicator function is not clear (Deng et al.,
2002, 2003).
The experiments presented here were undertaken to
identify essential protein–protein interactions and DNA
sequence elements responsible for the recruitment of
ORC to the replicator of oriP and for minimal replicator
activity. We show that nucleotides flanking the nonamer
repeats within the minimal replicator are not specifically
required for minimal replicator activity and that there is a
great deal of spatial flexibility in the spacing and
orientation of the nonamer repeats and EBNA-1 binding
sites. These results are consistent with a requirement for
TRF2 in oriP replicator function (Bianchi et al., 1999;
Deng et al., 2002). We also show that functional EBNA-
1 binding sites are essential for the recruitment of ORC
to the replicator and that EBNA-1 binding sites 4 and 3
are sufficient for the association of Orc2 with the
replicator. Finally, we have determined that three nucle-
otide differences between the DS element of the Raji
EBV genome and other EBV DS elements previously
examined are not solely responsible for the infrequent
initiation of DNA replication within oriP in the Raji
Table 1
Replication efficiencies of pHEBo-2.2.5 derivatives in which the 14-bp
repeats a and b are replaced by repeat c
Plasmid Replicatora Replication efficiencyb
pHEBo-2.2 Absent 0.86 F 0.13
pHEBo-1.1 WT 59 F 3.7
pHEBo-2.2.5 a-4-3-b 8.2 F 0.51
pHEBo-2.2.6 4-3 2.1 F 0.97
pHEBo-2.2.7 a-4-3 3.1 F 0.87
pHEBo-2.2.8 4-3-b 3.6 F 1.0
pHEBo-2.2.26 a-4-3-c 8.4 F 2.7
pHEBo-2.2.27 c-4-3-b 10 F 2.1
pHEBo-2.2.28 c-4-3-c 8.5 F 1.1
a Plasmids pHEBo-2.2.5 through -2.2.8 contain EBV nt 9019–9085
encompassing the 14-bp repeats a and b, and EBNA-1 binding sites 4 and
3 or a subset of these elements as indicated. The 14-bp repeats are replaced
by the 14-bp encompassing nonamer repeat c in pHEBo-2.2.26, -2.2.27,
and -2.2.28 as indicated.
b Replication efficiencies are the percentages of replicated test plasmid
DNA relative to replicated pHEBo-1 DNA per cell generation. The
numbers are means F standard deviations derived from three independent
determinations.
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1995).Results
Nucleotides flanking the nonamer repeats are not
specifically required for minimal replicator function
Our previous in vitro and in vivo analyses of the effects
of inactivating mutations within the EBNA-1 binding sites
of the oriP replicator suggested that a cellular protein binds
the 14-bp repeats a, b, and c and interacts physically withFig. 2. The 14-bp repeat c substitutes functionally for the related repeats a and b
2–10 and the internal control plasmid pHEBo-1 in triplicate. Low molecular weig
PstI (lane 2) or DpnI, EcoRV, PstI, and SacI (lanes 3–10). The digested samples we
nucleotides between FR and DS, and a representative blot is shown in the figure. L
with DpnI, EcoRV, and PstI (lane 1) to show the position of the Raji EBV fragmen
increased the mobility of the Raji EBV fragment complementary to the probe (EB
fragment (4.1 kb) derived from pHEBo-2.2 and its derivatives (see also Fig. 4) by p
in three independent determinations were used to calculate relative replication eff
pHEBo-1 and pHEBo-1.1 DNA, 2.3 kb and 2.9 kb, respectively, are indicated onEBNA-1 (Koons et al., 2001). To gain further insight into
protein–protein interactions that occur at the replicator of
oriP, we introduced mutations within the minimal replicator
and determined the effects of these mutations upon its
activity. The replicator of oriP is composed of multiple
functional elements (Koons et al., 2001; Yates et al., 2000),
and others have previously shown that mutation of all three
nonamer repeats in the context of intact oriP had no effect
upon long-term plasmid maintenance. However, mutations
within these repeats had a deleterious effect upon long-term
plasmid maintenance when present within oriP plasmids
containing only portions of the replicator (Yates et al.,
2000). A plasmid containing the minimal replicator,
pHEBo-2.2.5, was therefore selected as the parental plasmid
for the mutational analysis of the 14-bp repeats. We began
by replacing the 14-bp repeats a and b with the 14-bp repeat
c to determine if the nonamer core sequence present within
each of these repeats contains all the sequence information
necessary for the interaction of cellular proteins involved in
the initiation of DNA replication within oriP. Repeats a and
b are perfect 14-bp inverted repeats while repeat c differs
from repeats a and b in the 3 bp between its nonamer core
sequence and EBNA-1 binding site 1 and the 2 bp at its right
end (Fig. 1; nonamer core sequence is shown in boldface
type). Derivatives of an oriP plasmid containing the mini-
mal replicator in place of the DS element and the right-hand
flanking sequence (pHEBo-2.2.5; Fig. 1) were created in
which repeats a and b were replaced by repeat c. The
orientation of the nonamer core sequence was kept the same
as the orientation present with the non-mutagenized minimal
replicator in these derivatives (pHEBo-2.2.26, -2.2.27, and
-2.2.28). The replication efficiencies of these plasmids
relative to a reference oriP-bearing plasmid that replicates. Raji cells were co-electroporated with the plasmids indicated above lanes
ht DNA was isolated 72 h later and digested with either DpnI, EcoRV, and
re analyzed by Southern blotting with a probe consisting of oriP FR and the
ow molecular weight DNA from non-electroporated Raji cells was digested
t (4.4 kb) containing FR (EBV-SacI). The inclusion of SacI in the digestions
V + SacI; 2.7 kb) and allowed the quantitation of the replicated FR+ DNA
hosphorimaging. The ratios of replicated test plasmid to replicated pHEBo-1
iciencies (Table 1 and Materials and methods). The positions of replicated
the right side of the figure.
Fig. 3. Effects of insertions between the EBNA-1 binding sites and nonamer
repeats upon minimal replicator function. The ability of pHEBo-2.2.5
derivatives with insertions of 3 bp (pHEBo-2.2.29), 5 bp (pHEBo-2.2.30),
or 10 bp (pHEBo-2.2.31) between the EBNA-1 binding sites and the
flanking nonamer repeats to replicate in Raji cells was determined as
described in Fig. 2. pHEBo plasmids containing the minimal replicator
(pHEBo-2.2.5) or only EBNA-1 binding sites 4 and 3 (pHEBo-2.2.6) were
also included in this experiment to illustrate the effect of the 14-bp repeats a
and b upon replicator activity. Low molecular weight DNA isolated from
Raji cells co-electroporated with pHEBo-1.1 and pHEBo-1 (lane 2) was
digested with DpnI, EcoRV, and PstI, while the remaining samples were
digested with DpnI, EcoRV, PstI, and SacI (lanes 1 and 3–7). The positions
of the DNA fragments derived from replicated pHEBo-1 and pHEBo-1.1,
as well as the Raji EBV fragments produced with or without SacI digestion
(see also Fig. 4), are indicated on the right. The position of the DNA
fragments derived from pHEBo-2.2 and all other plasmids used in this
experiment is also indicated on the right (test plasmids).
Table 2
Replication efficiencies of pHEBo-2.2.5 derivatives containing insertions
between the 14-bp repeats a and b, and the adjacent EBNA-1 binding sites
Plasmid Replicatora Replication efficiencyb
pHEBo-2.2 Absent 0.52c
pHEBo-1.1 WT 88 F 1.6
pHEBo-2.2.5 a-4-3-b 9.9 F 0.57
pHEBo-2.2.6 4-3 2.8 F 0.07
pHEBo-2.2.29 a-i3-4-3-i3-c 9.9 F 0.94
pHEBo-2.2.30 a-i5-4-3-i5-c 6.9 F 0.86
pHEBo-2.2.31 a-i10-4-3-i10-c 4.8 F 0.13
a pHEBo-2.2.29, -2.2.30, and –2.2.31 contain insertions between the 14-bp
repeats a and b, and the neighboring EBNA-1 binding sites. The number of
base pairs (n) inserted is indicated by in.
b Replication efficiencies were determined as described in Table 1.
c Replication efficiency is for one determination. Replicated pHEBo-2.2
DNA was not detected in two other determinations.
Fig. 4. Spatial plasticity in the arrangement of the nonamer repeats in
relation to neighboring EBNA-1 binding sites. The ability of pHEBo-2.2.5
derivatives containing inversions of one (pHEBo-2.2.32) or both (pHEBo-
2.2.33) of the 14-bp repeats to replicate in Raji cells, in comparison to
pHEBo-2.2.5, was determined as described in Fig. 2. Low molecular weight
DNA isolated from Raji cells was digested with DpnI, EcoRV, PstI with
(lane 2) or without (lane 1) SacI to show the positions of the Raji EBV
DNA fragments produced by digestion with these enzymes. The positions
of the DNA fragments produced from replicated pHEBo-1 (internal control
plasmid), pHEBo-1.1, and all other plasmids analyzed in this experiment
(test plasmids) are indicated on the right.
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short-term replication assay (Koons et al., 2001). pHEBo-
2.2.5 derivatives lacking one or the other, or both, of the 14-
bp repeats, and which were previously shown to lack
replicator activity (pHEBo-2.2.6, -2.2.7, and -2.2.8; (Koons
et al., 2001), were also analyzed in this experiment. All
three plasmids with 14-bp repeat c replacements were
replicated as efficiently as the parental plasmid (P = 0.9–
1; Fig. 2 and Table 1). These results show that the 2 and 3
bp flanking the nonamer core sequence in repeats a and b
may be changed without affecting minimal replicator activ-
ity and thus establish the boundaries of the nucleotides
within the 14-bp repeats that are critical for function. The
ability of repeat c to substitute fully for repeats a and b is
consistent with previous results that suggested that repeat c
is functional (Koons et al., 2001).
Spatial flexibility in the functional elements of the minimal
replicator
To determine if a specific spatial relationship between
EBNA-1 and the nonamer repeat binding protein is required
for minimal replicator activity, we created two additionalsets of pHEBo-2.2.5 derivatives in which the spacing
between the nonamer repeats and EBNA-1 sites was in-
creased or the nonamer repeats were inverted relative to
their normal orientation within the minimal replicator. The
results of replication assays performed with plasmids con-
taining insertions between repeats a and b and the adjacent
EBNA-1 binding sites showed that the activity of the
minimal replicator was not reduced when the distance
between the 9-bp core sequence and the adjacent EBNA-1
site was increased by 3 bp (compare pHEBo-2.2.5 to
pHEBo-2.2.29; P = 1; Fig. 3 and Table 2). Note that in
Table 3
Replication efficiencies of pHEBo-2.2.5 derivatives in which the 14-bp
repeats are inverted
Plasmid Replicatora Replication efficiencyb
pHEBo-2.2 Absent N.D.c
pHEBo-1.1 WT 100d
pHEBo-2.2.5 a
!4 3 b
p
11 F 0.4
pHEBo-2.2.32 a
p4 3 b 11 F 1.4
pHEBo-2.2.33 a
p4 3 b
!
4.3 F 0.56
a Inversions of the 14-bp repeats in pHEBo-2.2.32 and -2.2.33 are indicated
by arrows.
b Replication efficiencies were determined as described in Table 2.
c N.D., not detected.
d The replication efficiency over three cell generations relative to pHEBo-1
was 114 F 4.2%.
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slightly better than pHEBo-2.2.29 (10% and 8.9%, respec-
tively), but a statistically significant difference in replication
efficiencies was not observed when these results were
combined with two additional measurements (Table 2).
However, increasing the spacing by 5 bp (pHEBo-2.2.30)
or 10 bp (pHEBo-2.2.31) reduced replication efficiency in
comparison to pHEBo-2.2.5 (P < 0.01; Fig. 3 and Table 2).
These results are consistent with the activity of the EBNA-
1 binding sites and the flanking repeats being dependent
upon one another, and further supported our hypothesis
that a cellular protein binds the nonamer repeats and
interacts functionally with EBNA-1. Surprisingly, a
pHEBo-2.2.5 derivative in which the orientation of repeat
a was inverted replicated as efficiently as the parental
plasmid harboring the minimal replicator (compare
pHEBo-2.2.32 to pHEBo-2.2.5; P = 1), but inversion of
both repeats a and b (pHEBo-2.2.33) resulted in a signif-
icant decrease in replication efficiency (Fig. 4 and Table
3). Thus, while interactions between EBNA-1 and the
nonamer binding protein are important for the binding of
the cellular protein to the replicator or for a subsequent
event in the initiation of replication, these interactions can
withstand certain, but not all, alterations in the arrange-
ment of the binding sites.Fig. 5. In vivo association of EBNA-1 and Orc2 with WT and mutated oriP replica
chromatin isolated from 293-EBNA cells harboring p174XS derivatives containing
the p174XS derivatives, shown as a linear molecule to facilitate presentation of t
aliquoted and used as template for real-time PCR using primer pairs (arrows) for t
intervening regions A and B were also used to monitor the separation of WT oriP fr
in the figure are the fold enrichment of chromatin containing the indicated regions o
comparison to normal rabbit antibodies and were calculated as described in MateThe binding of EBNA-1 to the replicator of oriP is required
for the in vivo association of ORC with the replicator
We wished to use the chromatin immunoprecipitation
(ChIP) method to investigate EBNA-1 and sequence
requirements for the recruitment of ORC to the oriP
replicator in vivo. It was not possible to establish stable
transformants of EBNA-1-expressing cells containing
pHEBo-1.1 derivatives with test replicators that function
inefficiently, or are inactive, for these ChIP experiments. To
circumvent this technical obstacle, different mutated test
replicators were individually introduced into a large oriP
plasmid (p174XS) opposite the WT replicator such that the
test replicators were separated from the WT replicator by 7.3
kb and from FR by 8.1 kb. The replication of the parental
plasmid to p174XS, p174, has been characterized by two-
dimensional agarose gel electrophoresis and all initiation
events were observed to localize to oriP (Gahn and Schildk-
raut, 1989). Additionally, replication origins were not ob-
served in the additional EBV DNAwe introduced into p174
to create p174XS (Norio and Schildkraut, 2001), and there
are no EBNA-1 binding sites within p174XS outside of
oriP. We therefore did not expect to find EBNA-1 or ORC
associated with regions of p174XS other than oriP and
certain test replicators. Clonal populations of 293-EBNA
cells harboring these p174XS derivatives were isolated and
clones with plasmid copy numbers ranging between 55 and
83 copies per cell were identified by Southern blot analysis
of low molecular weight DNA (data not shown). Intact cells
in actively dividing, asynchronous cultures were treated
with formaldehyde to cross-link proteins to DNA and the
cross-linked chromatin was sheared by sonication and
purified on CsCl-Sarkosyl gradients (Orlando et al., 1997).
The chromatin was digested with micrococcal nuclease
(MNase) to further reduce the size of the chromatin frag-
ments to an average size of approximately 1.5 kb and
physically dissociate WT oriP from the test replicators.
Aliquots of the chromatin were immunoprecipitated with
antibodies to EBNA-1, Orc2 (a core component of ORC
(Dhar et al., 2001a; Ohta et al., 2003; Vashee et al., 2001)
326 (2004) 317–328 321tors. Rabbit antibodies to EBNA-1 or Orc2 were used to immunoprecipitate
the test replicators indicated in the column on the left. A schematic view of
he data, is shown at the top of the figure. The DNA within the ChIPs was
he DS element within WT oriP or the test replicator region. Primers for the
om the test replicator region by sonication and MNase digestion. The values
f the p174XS derivatives when antibodies to EBNA-1 or Orc2 were used in
rials and methods.
Fig. 6. Replication of pHEBo-1.1 (dpm1–4) and pHEBo-1.1subRaji DS.
Low molecular weight DNA was isolated from Raji cells (lane 1) or Raji
cells 72 h following co-electroporation with pHEBo-1 and the plasmids
indicated above each lane (lanes 2–5). The samples were digested with
DpnI, EcoRV, and PstI (lanes 1, 3–5) or DpnI, EcoRV, PstI, and SacI (lane
2), and analyzed by Southern blotting as described in Fig. 2. The positions
of the fragments derived from the Raji EBV genome with or without SacI
digestion, and the replicated DNA fragments derived from pHEBo-1 and
the various test plasmids, are indicated on the right. The position of the
fragment derived from replicated pHEBo-2.2, which was not detected in
this representative experiment, is indicated by the asterisk on the left.
Table 4
Replication efficiencies of pHEBo-1.1subRaji DS and pHEBo-1.1 (dpm1–4)
Plasmid Replication efficiencya
pHEBo-2.2 0.63 F 0.21
pHEBo-1.1 100b
pHEBo-1.1subRaji DS 89 F 3.3
pHEBo-1.1 (dpm1–4) 1.5 F 0.42
a Replication efficiencies were determined as described in Table 2.
b Replication efficiency over three cell generations relative to pHEBo-1 was
89 F 6.0%.
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2001b) and is localized to oriP throughout the cell cycle
(Chaudhuri et al., 2001)), or control antibodies. The immu-
noprecipitation of WT oriP-containing chromatin or the test
replicator was quantitated by performing real-time PCR on
aliquots of each ChIP using primer pairs specific for these
two regions of the plasmid (Fig. 5). The data are reported as
the fold enrichment of chromatin containing the indicated
region of the plasmid with antibodies to EBNA-1 or Orc2
compared to ChIPs performed in parallel with control anti-
bodies. Because p174XS plasmids containing individual test
replicators also contained WT oriP, each ChIP contains an
internal control for the presence and integrity of the anti-
bodies and the recovery of the immunoprecipitated DNA.
The physical separation of the WT and test replicators by
sonication and MNase digestion was monitored by
performing real-time PCR on aliquots of each ChIP with
primer pairs specific to regions of the plasmid approximate-
ly halfway between the WT and test replicators (control
regions A and B; Fig. 5), and these comparisons revealed
that long pieces of chromatin containing WT oriP and
regions A or B were largely, albeit not completely, elimi-
nated by MNase digestion.Using this experimental approach, we asked if the bind-
ing of EBNA-1 to the replicator is required for the associ-
ation of ORC with oriP. We first constructed a pHEBo-1.1
derivative in which all four EBNA-1 binding sites in the
replicator were rendered incapable of binding EBNA-1 by
introducing base pair transversions at the +5/5 positions of
each site (Harrison et al., 1994). As anticipated by the
requirement for EBNA-1 for oriP-plasmid replication
(Yates et al., 2000) and a specific spatial arrangement of
the EBNA-1 binding sites for replicator activity (Bashaw
and Yates, 2001; Harrison et al., 1994), the level of
replication of this plasmid, pHEBo-1.1(dpm1–4), was in-
distinguishable from a plasmid lacking the DS element,
pHEBo-2.2 (P = 0.9; Fig. 6 and Table 4). EBV nt 8992–
9137, encompassing all four EBNA-1 binding sites, repeats
a, b, and c, and 27 bp of left-hand flanking sequence (Fig.
1B) and the same fragment of EBV DNA from pHEBo-1.1
(dpm1–4) were introduced into p174XS, and ChIP experi-
ments were performed with 293-EBNA cells containing
these plasmids (Fig. 5). The association of both EBNA-1
and Orc2 with the WT replicator was readily apparent, as
was the association of EBNA-1 and Orc2 with the test
replicator 8992–9137. The inability or decreased ability of
antibodies to Orc2 and EBNA-1 to enrich for chromatin
containing the control regions A and B in comparison to the
control antibodies showed that the association of EBNA-1
and Orc2 with the test replicator 8992–9137 was not due to
the presence of long pieces of chromatin containing both
WT oriP and this test replicator. Mutation of the EBNA-1
binding sites in the test replicator 8992–9137 (dpm1–4)
greatly reduced the enrichment of this region of the plasmid
with antibodies to EBNA-1 compared to control antibodies
(17-fold for the test replicator 8992–9137 [dpm1–4] com-
pared to 315-fold for the test replicator 8992–9137). Two
observations argue that the level of enrichment observed for
chromatin containing the test replicator 8992–9137
(dpm1–4) was due to the presence of long chromatin
fragments containing both the WT oriP and the test
replicator and not the result of EBNA-1 binding to
8992–9137 (dpm1–4). The fold enrichments of the control
regions A and B, which lack EBNA-1 binding sites, with
anti-EBNA-1 antibodies in comparison to control antibod-
ies were either greater or the same as was observed with the
test replicator 8992–9137 (dpm1–4) (76- and 18-fold,
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ing the control regions had survived sonication and MNase
digestions and were immunoprecipitated by virtue of the
presence of the WT replicator or FR. Also, the distance
between control region A and oriP FR is less than the
distance between control region B and the WT replicator,
and a greater fold enrichment was obtained with region A
than with region B for both test replicators 8992–9137 and
8992–9137 (dpm1–4). Concomitant with the reduced en-
richment of chromatin containing the test replicator 8992–
9137 (dpm1–4) with antibodies to EBNA-1 was the loss of
association of Orc2 with the test replicator (Fig. 5). These
results demonstrate directly that EBNA-1 is required for the
recruitment of a core component of ORC (Orc2) to the
replicator.
The nonamer repeats within the minimal replicator are
dispensable for the association of Orc2 with the oriP
replicator
The results description above showed that EBNA-1 is
required for the association of Orc2 with the replicator of
oriP. Because the nonamer repeats are required for minimal
replicator activity and the previous experiment did not
exclude a requirement for a nonamer repeat binding protein
in the recruitment of Orc2, we performed experiments to
determine whether this ORC subunit associates with an
inactive replicator consisting of EBNA-1 binding sites 4
and 3. As a positive control for this experiment, we
investigated the in vivo association of Orc2 with the
minimal replicator (a-4-3-b). The test replicators were
introduced into p174XS and formaldehyde-cross-linked
chromatin was prepared from 293-EBNA cells harboring
these two plasmids. As anticipated by the ability of purified
EBNA-1 to bind DNA site-specifically (Frappier and
O’Donnell, 1991; Hearing et al., 1992), antibodies to
EBNA-1 precipitated chromatin containing both test repli-
cators (a-4-3-b and 4-3; Fig. 5) to a significantly greater
extent than control antibodies (239- and 437-fold enrich-
ments for a-4-3-b and 4-3, respectively) and the control
regions A and B that lack EBNA-1 binding sites (Fig. 5).
Antibodies to Orc2 also enriched for chromatin containing
these two test replicators in a similar manner, demonstrating
that the 14-bp repeats and, thus, the nonamer repeat binding
protein(s) are not required for the association of Orc2 with
the replicator of oriP.
Replication initiation from the Raji EBV oriP replicator
In vivo foot-printing experiments performed with the
Raji EBV-positive Burkitt’s lymphoma cell line determined
that EBNA-1 is bound to all four sites within the replicator
throughout most, or all, of the cell cycle (Hsieh et al., 1993).
The number and spatial arrangement of the EBNA-1 bind-
ing sites in the Raji and B95-8 oriP replicators are identical,
as are the nonamer repeats (Koons et al., 2001), yetreplication initiates inefficiently within oriP in the Raji
EBV genome (Little and Schildkraut, 1995). Only three
differences exist in DS between the Raji and B95-8 EBV
genomes: an A-to-T transversion at nt 9008 and A-to-G
transitions at nt 9019 and 9062 (indicated by asterisks in
Fig. 1B) (Koons et al., 2001; Salamon et al., 2000). The
base pair transition at position 9062 is present within oriP
from several EBV isolates, but the differences at positions
9008 and 9019 have not been observed in other isolates
(Koons et al., 2001; Salamon et al., 2000). To determine if
these differences are responsible for the low frequency with
which replication initiates within oriP in the Raji EBV
genome, we replaced EBV (B95-8 strain) nt 8995–9134
in pHEBo-1.1 with the same sequence from the Raji EBV
genome and determined how efficiently this plasmid
(pHEBo-1.1subRaji DS) replicated in a short-term replica-
tion assay. This substitution modestly reduced the replica-
tion efficiency of pHEBo-1.1, suggesting that one or more
of the three nucleotide differences between the Raji and
B95-8 EBV genomes do affect the assembly or function of a
pre-replication complex (P < 0.01; Fig. 6 and Table 4).
However, the magnitude of this effect cannot account for the
greatly reduced frequency with which replication initiates
within oriP in the Raji EBV genome.Discussion
The cell cycle-regulated replication of oriP plasmids is
coordinated by the assembly of a pre-replication complex
(pre-RC) at, or near, a replicator that contains four binding
sites for EBNA-1, the sole viral protein required for oriP-
plasmid DNA replication (Schepers et al., 2001). Chromatin
immunoprecipitation experiments have directly demonstrat-
ed that this pre-RC contains human ORC and MCM
proteins (Chaudhuri et al., 2001; Dhar et al., 2001b;
Schepers et al., 2001), and the presence of Cdt1, an MCM
loading factor (Wohlschlegel et al., 2000 and references
therein), has been inferred by the inhibitory action of
geminin on oriP-plasmid replication (Dhar et al., 2001b).
Because the replication of plasmids bearing oriP is almost
entirely dependent upon the cellular replication machinery,
it is likely that most, if not all, of the other components of
the pre-RCs that assemble at chromosomal origins of DNA
replication are present within the oriP pre-RC. We report in
this paper an investigation of the molecular requirements for
the in vivo association of a subunit of ORC, Orc2 (Dhar et
al., 2001a; Ohta et al., 2003; Vashee et al., 2001), with the
replicator of oriP by immunoprecipitation of formaldehyde-
cross-linked chromatin. In contrast to the well-studied
situation in S. cerevisiae, the entrance of Orc1 and possibly
Orc6 into the ORC complex at the pre-RC is cell cycle-
regulated in human cells (Depamphilis, 2003), and a sub-
assembly consisting only of Orc2, Orc3, Orc4, and Orc5
likely forms a core ORC complex that is present at human
replication origins throughout the cell cycle (Dhar et al.,
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2001). We used antibodies to Orc2 to monitor the recruit-
ment of ORC to the oriP replicator in these experiments as
this subunit has been previously shown to be a component
of the oriP pre-RC (Chaudhuri et al., 2001; Schepers et al.,
2001) and is a component of the core ORC complex (Orc2–
5) that associates with oriP throughout the cell cycle (Ritzi
et al., 2003). ORC was unable to associate with an inactive
oriP replicator in which all four EBNA-1 sites were disabled
by double point mutations, thus directly demonstrating an
absolute requirement for DNA-bound EBNA-1 for the
recruitment of ORC to oriP. It has been previously shown
that the replication of oriP-plasmids is defective in human
cells containing a hypomorphic mutation in the ORC2 gene
(D-ORC2/- cells; Dhar et al., 2001b). These cells have
greatly reduced levels of chromatin-bound DOrc2, Orc3,
and Orc4 and exhibit a longer G1-phase of the cell cycle in
comparison to parental cells. The decreased ability of oriP
plasmids to replicate in D-ORC2/- cells showed that Orc2 is
required for the initiation of DNA replication from within
oriP (Dhar et al., 2001b). Together with these results, our
finding that replicator-bound EBNA-1 is required for the
association of Orc2 with oriP allows us to conclude that one
of the perhaps multiple essential roles of EBNA-1 in oriP
plasmid replication is the recruitment of ORC. Future
experiments will be aimed at determining whether the
recruitment of Orc1 (Schepers et al., 2001) requires se-
quence elements that are dispensable for the association of
the core ORC complex with the replicator and whether Orc6
is a component of the oriP pre-RC.
We have previously shown that minimal replicator activ-
ity is associated with a fragment of oriP containing EBNA-1
binding sites 4 and 3 and the flanking 14-bp repeats a and b
(Koons et al., 2001), and we therefore anticipated that ORC
would be recruited to a site containing these functional
elements (a-4-3-b). Not only did Orc2 antibodies specifi-
cally immunoprecipitate chromatin containing a-4-3-b but
they also immunoprecipitated chromatin containing a 37-bp
fragment of the minimal replicator containing only EBNA-1
binding sites 4 and 3. Thus, the 14-bp repeats are not
required for the association of a subunit of the core ORC
complex, Orc2, with the replicator of oriP. These ChIP
results do not exclude the presence of ORC-DNA contacts
that may occur within the EBNA-1 recognition element, the
5 bp between these two EBNA-1 sites, or in the flanking
DNA, but the conclusion that EBNA-1–ORC interactions
are sufficient for the association of ORC with the replicator
is supported by the co-immunoprecipitation of EBNA-1 and
the ORC subunits Orc1, Orc2, and Orc3 from nuclear
extracts (Schepers et al., 2001). Four ORC subunits have
been found to make direct contact with the ARS consensus
sequence and B1 elements of the S. cerevisiae origin ARS1
(Lee and Bell, 1997), and both Orc1 and Orc2 have been
found to contact the DNAwithin the human lamin B2 origin
(Abdurashidova et al., 2003). Furthermore, short regions of
homology between S. cerevisiae ARS1 B1 element and theDrosophila melanogaster ACE3, hamster ori-h, and human
h-globin and lamin B2 origins have been described (Bogan
et al., 2000), suggesting that ORC makes sequence-specific
contacts within all of these origins. Although EBNA-1–
ORC interactions may be sufficient for the association of
ORC with the replicator, additional experiments are required
to determine if ORC–DNA interactions are required for
ORC to function in oriP plasmid replication or whether
DNA-bound EBNA-1 provides the necessary DNA binding
activity for ORC function. If EBNA-1 can functionally
replace the DNA binding activity of ORC and target ORC
to chromosomal loci for which it has no innate DNA
binding specificity, this activity would raise the possibility
that certain chromosomal origins may be determined by
novel ORC-associated DNA binding proteins.
The 14-bp repeats within the minimal replicator contain a
9-bp core sequence (5V-TTAGGGTTA-3V) that resembles
telomeric DNA. Two cellular proteins that bind telomeres,
TRF1 and TRF2, have been reported to bind the oriP
nonamer repeats in vitro and in vivo (Deng et al., 2002,
2003), and several proteins that associate with TRF1 and
TRF2 at telomeres have also been identified in complexes
with oriP DNA (Deng et al., 2002, 2003). In addition,
methods that reduced the binding of TRF2 to telomeres
attenuated the replication of oriP-plasmids, consistent with a
positive role for TRF2 in the initiation of DNA replication at
this viral origin (Deng et al., 2002, 2003). We have
performed a mutational analysis of the minimal replicator
14-bp repeats and have determined that base pairs outside of
the nonamer core sequence are not required for minimal
replicator activity. Furthermore, minimal replicator function
was not abrogated by certain changes in the arrangement of
the nonamer repeats and EBNA-1 binding sites such as
inversion of one of the two repeats or the insertion of 3 bp
and, to a lesser extent, 5 bp between the EBNA-1 sites and
the nonamer repeats. Although the minimal replicator tol-
erated these alterations in the spatial arrangement of EBNA-
1 binding sites and nonamer repeats, activity was greatly
reduced by 10-bp insertions between these elements or the
inversion of both nonamer repeats relative to their native
orientation. These results provide additional support for our
hypothesis that EBNA-1 interacts functionally with the
nonamer repeat binding protein (Koons et al., 2001).
TRF1 binds to telomeric repeats as a homodimer and the
half sites that compose the TRF1 recognition element show
a tremendous amount of flexibility with regards to their
spatial arrangement (Bianchi et al., 1999). This flexibility
has been attributed to a putative hinge region between the
Myb-type DNA binding domain and the dimerization do-
main of TRF1 that shows poor conservation between mouse
and human proteins (Broccoli et al., 1997a). TRF2 also has
a non-conserved region located between a dimerization
domain and a Myb DNA binding domain, and is thought
to bind DNA in the same manner as TRF1 (Bianchi, 1999;
Broccoli et al., 1997b). EBNA-1 bends DNA to which it is
bound site-specifically and the total bend induced by
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replicator, which are in helical phase with one another,
has been estimated at 100j (Bashaw and Yates, 2001).
Furthermore, the spacing between these sites is critical,
suggesting that the nature of the bend is important either
for the unwinding of the DNA during the initiation of DNA
replication or for the formation of a specific nucleoprotein
structure that is required for the recruitment of ORC
(Bashaw and Yates, 2001; Harrison et al., 1994). At present,
we can only speculate as to whether the interaction of
EBNA-1 with TRF2 is sufficient to allow for the stable
binding of TRF2 to the replicator or whether the bending of
the replicator by EBNA-1 brings the DNA-bound TRF2
monomers in proximity so that homodimerization can occur.
In this latter situation, the putative hinge region within
TRF2 would be expected to facilitate the interaction of
monomers bound to distant half sites. In either case, the
results presented here demonstrate that the role for TRF2 in
oriP replicator function lies upstream or downstream of the
recruitment of the core complex of ORC.
The number and arrangement of EBNA-1 binding sites
within the oriP replicator, as well as the presence of flanking
nonamer repeats, are conserved among different EBV iso-
lates, and there are few, if any, nucleotide differences within
DS or the flanking sequences (Koons et al., 2001). Repli-
cation initiates infrequently from oriP in the Raji EBV
genome in comparison to Burkitt’s lymphoma cell lines
harboring different EBV strains, and this difference appears
to be a cis effect as recombinant oriP plasmids replicate
efficiently in Raji cells (Koons et al., 2001; Yates and Guan,
1991). The Raji EBV genome differs from the B95-8 EBV
genome in three base pair positions within oriP DS (Koons
et al., 2001), and two of these differences are present in a
24-bp region to the left of nonamer repeat a that has been
suggested to contribute to oriP function (Koons et al.,
2001). An oriP plasmid bearing the Raji DS element
replicated less efficiently than a corresponding plasmid
containing the B95-8 EBV DS element, further supporting
a role for nucleotides to the left of the minimal replicator in
DS to replicator activity. However, these differences are not
solely responsible for the reduced efficiency with which
replication initiates within oriP in the Raji EBV genome.
Thus, it seems likely that additional genetic or epigenetic
differences between the Raji EBV genome and the genomes
of other EBV strains contribute to the reduced activity of the
Raji oriP.Materials and methods
Cells
The EBV-positive Burkitt’s lymphoma cell line Raji
(Pulvertaft, 1964) was cultured in RPMI 1640 medium
supplemented with 10% fetal bovine serum (HyClone
Laboratories) and 100 units each of penicillin and strepto-mycin per ml at 37 jC in a humidified atmosphere contain-
ing 5% CO2. The EBNA-1-expressing human cell line 293-
EBNA was obtained from Invitrogen and maintained in
DMEM medium supplemented with 10% fetal bovine
serum, 100 units each of penicillin and streptomycin per
ml, and 250 Ag Geneticin (Life Technologies) per ml. 293-
EBNA cells were also cultured at 37 jC in a humidified
atmosphere containing 5% CO2.
Plasmids
pHEBo-1 and its derivative, pHEBo-1.1, harbor EBV
nt 7333–9516 (B95-8 strain) encompassing oriP and
differ only in the absence of 342 bp of plasmid backbone
from pHEBo-1.1 (Hearing et al., 1992). pHEBo-2.2 was
derived from pHEBo-1.1D9138–9516 by deletion of
EBV nt 8995–9140 (Koons et al., 2001). The construc-
tions of pHEBo-2.2.5, -2.2.6, -2.2.7-, and -2.2.8 have
been described (Koons et al., 2001). Derivatives of
pHEBo-2.2.5 that contain 14 bp encompassing nonamer
repeat c (EBV nt 9124–9137) in place of EBV nt 9070–
9083 (14-bp repeat containing nonamer repeat b; pHEBo-
2.2.26), the complement of EBV nt 9124–9137 in place
of EBV nt 9019–9032 (14-bp repeat containing nonamer
repeat a; pHEBo-2.2.27), and both EBV nt 9124–9137
in place of EBV nt 9070–9083 and the complement of
EBV nt 9124–9137 in place of EBV nt 9019–9032
(pHEBo-2.2.28) were constructed by ligating double-
stranded oligonucleotides with 5V extensions containing
these sequences to double-stranded oligonucleotides with
5V complementary extensions containing EBNA-1 binding
sites 4 and 3 and inserting these synthetic DNA frag-
ments into the BamHI site of pHEBo-2.2. This same
approach was used to introduce 3 bp (5V-CTG-3V; pHEBo-
2.2.29), 5 bp (5V-CTGCT-3V; pHEBo-2.2.30), and 10 bp
(5V-CTGCTGCTGC-3V; pHEBo-2.2.31) between the 14-bp
repeats a and b and EBNA-1 binding sites 4 and 3,
respectively, within pHEBo-2.2.5. Plasmids pHEBo-2.2.32
and -2.2.33, derivatives of pHEBo-2.2.5 in which the 14-
bp a repeat or both the 14-bp a and b repeats, respec-
tively, were inverted relative to their normal orientation,
were similarly constructed from double-stranded oligonu-
cleotides. One base pair was added at the end of these
inverted sequences to separate the nonamer repeats and
the flanking EBNA-1 binding sites by 3 bp as is found
in the wild-type minimal replicator.
Plasmid p174 contains EBV nt 101947–113282 inserted
between the BamHI and SalI sites of pHEBo2 (Yates et al.,
1985). The XhoI site at EBV nt 112799 was eliminated by
ligating the large XbaI–SalI fragment of p174 to the small
XbaI –XhoI fragment of p174. The resulting plasmid,
p174XS, contains a unique XhoI site approximately opposite
oriP. EBV nt 8994–9137 with XhoI ends was amplified by
PCR and inserted into the XhoI site of p174XS to create
p174XS (8992–9137). All four EBNA-1 binding sites
within the DS element of pHEBo-1.1 were inactivated by
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mutating sites 3 and 4 within pHEBo-1.1 (dpm1 + 2) by
oligonucleotide-directed mutagenesis as previously de-
scribed (Harrison et al., 1994). The plasmid thus created,
pHEBo-1.1(dpm1–4), was used as template to obtain EBV
nt 8992–9137 with XhoI ends by PCR. This fragment was
inserted into the XhoI site of p174XS to create p174XS
(8992–9137; dpm1–4). In a similar manner, p174XS deriv-
atives containing EBV nt 9019–9085 and 9033–9085,
p174XS(a-4-3-b), and p174XS(4-3), respectively, were con-
structed. The EcoRV–HpaI fragment of pHEBo-1.1 con-
taining EBV nt 8994 – 9134 was replaced with the
homologous EcoRV–HpaI fragment from the Raji EBV
genome (nt 8994–9134) obtained from pBluescript/KS
(Raji) (Harrison et al., 1994) to yield pHEBo-1.1subRaji DS.
Short-term replication assays
The impact of mutations within the DS element of oriP
upon DNA replication was determined by a quantitative
short-term replication assay (Koons et al., 2001). Briefly,
test plasmids were co-electroporated with a reference plas-
mid that replicates once per cell cycle (pHEBo-1; (Yates
and Guan, 1991) into Raji cells and the cells were main-
tained in a continuously dividing state for 72 h. The
inclusion of pHEBo-1 in each electroporation controlled
for small sample-to-sample variations in electroporation
efficiency and recovery of plasmid DNA from the cells.
Low molecular weight DNAwas isolated from the cells and
restricted with DpnI to digest nonreplicated DNA into
relatively small fragments and with a combination of other
restriction enzymes to yield larger diagnostic fragments
representing replicated test and reference plasmid DNA.
The relative amount of replicated test and reference plasmid
DNA was determined by Southern blotting with a probe
consisting of a BamHI–EcoRV fragment from pHEBo-1
that contains oriP FR and analysis of the blots with a
Molecular Dynamics Storm 860 phosphorimager. Scans
were quantitated with ImageQuant software (Molecular
Dynamics) and the replicative ability of the test plasmids
per cell cycle, determined in triplicate, was calculated as
previously described (Koons et al., 2001).
Derivation of 293-EBNA cells harboring p174XS derivatives
293-EBNA cells were transfected with derivatives of
p174XS containing various test replicators at the unique
XhoI site by the calcium phosphate co-precipitation method
(Graham et al., 1979), and cell clones containing the
plasmids were selected by culturing the cells in the presence
of hygromycin (Roche Molecular Biochemicals). Five to six
clones from each transfection were expanded under constant
drug selection and the copy numbers of the p174XS
derivatives within these cell clones were determined by
Southern blot analysis of low molecular weight DNA
(Koons et al., 2001). Varying amounts of p174XS (between25 and 250 pg) were analyzed on the same blots and the
amount of plasmid DNA per cell was determined by
phosphorimaging of the blots, quantitation of the scans
using ImageQuant software, and construction of a standard
curve from the p174XS values. The copy numbers of the
clones chosen for the chromatin immunoprecipitation
experiments were 74 copies/cell (293-EBNA: p174XS
(8992–9137)), 55 copies per cell (293-EBNA:p174XS
(8992 – 9137;dpm1 – 4)), 76 copies per cell (293-
EBNA:p174XS (a-4-3-b)), and 83 copies per cell (293-
EBNA:p174XS(4-3)).
Chromatin immunoprecipitations
Ten 150-mm dishes containing 293-EBNA cells harbor-
ing p174XS derivatives at approximately 80% confluency
were washed twice with phosphate-buffered saline (PBS)
and treated with PBS containing 1% formaldehyde for 20
min at 37 jC to cross-link proteins to DNA. Cross-linked
chromatin was prepared by the method of Chaudhuri et al.
(2001) and purified by equilibrium centrifugation on CsCl-
Sarkosyl gradients (Orlando et al., 1997). Peak fractions
containing protein–DNA complexes (refractive index of
1.37) were pooled, dialyzed against 10 mM Tris–HCl (pH
8.0), 1 mM EDTA, 0.5 mM EGTA, 5% glycerol at 4 jC, and
stored in aliquots at 80 jC. The concentration of DNA in
each chromatin preparation was determined by treating an
aliquot with 50 Ag RNase A/ml for 30 min at 37 jC,
adjusting the sample to 0.5% SDS, and digesting with 500
Ag proteinase K/ml for 16 h at 37 jC. The cross-links were
subsequently reversed by incubation at 65 jC for 6 h. The
samples were extracted twice with phenol-CHCl3, twice with
CHCl3, precipitated with ethanol, and the DNA concentra-
tion was determined spectrophotometrically.
Aliquots of chromatin were adjusted to 3 mM CaCl2 and
digested with 0.5 unit micrococcal nuclease (MNase) for
varying times at 37 jC. Digestion was stopped by the
addition of EGTA and the DNA in each sample was purified
as described above. The size distribution of the DNA in the
MNase-digested chromatin was analyzed by agarose gel
electrophoresis and samples containing DNA fragments
averaging approximately 1–2 kb were chosen for immuno-
precipitations. Aliquots of chromatin containing 60 Ag DNA
were adjusted to 150 mM NaCl, 60 mM Tris–HCl (pH 8.0),
1.5 mM EDTA, and 0.5% NP40, and incubated with
antibody 12–16 h at 4 jC. A rabbit anti-EBNA-1 antiserum
(2.5 Al; Van Scoy et al., 2000) was used to precipitate
chromatin containing EBNA-1 and chromatin containing
ORC was precipitated with 10 Al of a rabbit antiserum raised
against human Orc2 (PharMingen). Equivalent volumes of
normal rabbit serum were used to prepare control chromatin
immunoprecipitates. Protein A-Sepharose Cl-4B (Sigma-
Aldrich), pretreated 12–16 h at 4 jC with 1 mg salmon
sperm DNA/ml, 1 mg yeast tRNA/ml, 1 mg bovine serum
albumin/ml, and 1 NET (150 mM NaCl, 50 mM Tris–HCl
[pH 8.0], 1 mM EDTA, and 0.5% NP40), and washed three
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complexes. The beads were pelleted and washed (Chaudhuri
et al., 2001) and the immunoprecipitated DNA purified as
described above except Qiagen MinElute cartridges, used as
described by the manufacturer, were employed to concen-
trate the DNA following the reversal of the formaldehyde-
induced cross-links.
Real-time PCR
The amount of chromatin DNA immunoprecipitated with
antibodies to EBNA-1, Orc2, or control antibodies and
which contained oriP DS, the test replicators, or control
regions (A and B) situated between oriP DS and the test
replicators was quantitated by real-time PCR. The region of
p174XS containing WT oriP DS was amplified with primers
5V-GGAATCCTGACCCCATGTAAAT-3V and 5V-TCTGT-
GGACTGCAACACAACAT-3V, and portions containing
the test replicators were amplified with primers 5V-
AGAGCCCTGACATCCTT-AACAT -3V and 5V-GTCTATG-
TATTCAGCGCAGTCA-3V. The resulting PCR products
were 396 bp (WT oriP DS), 381 bp (8992–9137 and
8992–9137 [dpm1–4]), 300 bp (a-4-3-b), and 272 bp (4-
3). Primer pairs 5V-CTCGTCGTTTGGTATGGCTTCA-3V
and 5V-CTCAACAGCGGTAAGATCCTTG-3V and 5V-
TAACCACCCTGGAGACTCTTTA-3V and 5V-TAATAT-
CAGAGGGGTC-GCAAAA -3V were used to amplify con-
trol regions A and B, respectively, and yielded 383 bp
(control region A) and 325 bp (control region B) products.
One-sixth of the DNA present within each immunoprecipi-
tate was used as template for real-time PCR using the
LightCycler FastStart DNA Master SYBR Green I kit and
LightCycler instrument (Roche Molecular Biochemicals).
Real-time PCR was performed and quantitated as previously
described (Schepers et al., 2001). Briefly, varying amounts
of purified DNA from each chromatin preparation used
for ChIP, ranging between 100 and 100 ng in 10-fold
increments, were analyzed by real-time PCR with each
primer pair at the same time as the amplification of the
immunoprecipitated DNA. The second derivative method
was used to calculate the crossing points (Cp) from
reactions containing purified DNA and these values were
utilized to construct a standard curve of Cp versus the
logarithm of the concentration of DNA. The slope of this
standard curve was determined by linear regression and
the efficiency with which the PCR product was amplified
(Econst) was calculated by the equation Econst = 10
1/slope.
To determine the fold enrichment of a specific region of
the plasmid in immunoprecipitations performed with anti-
bodies to EBNA-1 or Orc2 in comparison to immuno-
precipitations performed with control antibodies, the
equation Ncontrol antibody  Nexperimental antibody = N0 
(Econst)
n(control antibody)  N0  (Econst)n(experimental antibody)
was solved, where N is the number of molecules at the
end of the amplification reaction and N0 is the number of
template molecules in each immunoprecipitation.Acknowledgments
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